A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/2001
11/28/2001	EP1157040A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
11/28/2001	EP1157021A1 Sulfamato hydroxamic acid metalloprotease inhibitor
11/28/2001	EP1157001A1 Oxamic acids and derivatives as thyroid receptor ligands
11/28/2001	EP1157000A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
11/28/2001	EP1156820A1 Vascular endothelial growth factor-2
11/28/2001	EP1156794A1 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using r(-)-ketoprofen
11/28/2001	EP0783503B1 2,7-substituted octahydro-1h-pyrido[ 1,2-a]pyrazine derivatives
11/28/2001	EP0660716B1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
11/28/2001	CN1324367A Cyclic prosaposin-derived peptides and uses thereof
11/28/2001	CN1324353A Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/28/2001	CN1324349A Pyrazine compounds
11/28/2001	CN1324251A Method of stimulating prosaposin receptor activity
11/28/2001	CN1324243A Method for treating inflammatory inflammatory diseases using heat shock proteins
11/28/2001	CN1324242A Novel NEUROPILIN/growth factor binding and use thereof
11/28/2001	CN1324240A Treatment of disorders of the outer retina
11/28/2001	CN1323619A Eyesight-strengthening and inflammation-resisting health food
11/28/2001	CN1323600A Compound cassia seed eye drops
11/28/2001	CN1323595A Composite medicine for glaucoma
11/28/2001	CN1323594A Hot compressed composite medicine for cataract
11/28/2001	CN1323592A Dressed composite medicine for treating vitreous body diseases
11/28/2001	CN1323584A External-use medicine liquid for diseases of eye, ear, nose and throat
11/28/2001	CN1075517C Method for extracting solomonscal polyose from Chinese herb medicine solomonseal rhizome
11/27/2001	US6323242 Treatment of disorders secondary to organic impairments
11/27/2001	US6323214 Allosteric adenosine receptor modulators
11/27/2001	US6323208 Compounds to treat neurodegenerative, psychotropic drug and alcohol induced central and induced central and peripheral nervous system disorders.
11/27/2001	US6323199 Aromatic heterocyclic hydroxy amines or amides for treatment of inflammation
11/27/2001	US6323187 Therapeutic dinucleotide and derivatives
11/27/2001	CA2021329C Di-aromatic esters, process for their preparation and use in human or veterinary medicine and as cosmetic compositions
11/22/2001	WO2001088129A1 Anti-angiogenic polypeptides
11/22/2001	WO2001088116A2 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
11/22/2001	WO2001087935A2 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
11/22/2001	WO2001087913A2 Method for treating retinal degeneration with purinergic receptor agonists
11/22/2001	WO2001087890A1 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
11/22/2001	WO2001087883A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
11/22/2001	WO2001087870A1 Hydroxamic acid derivatives
11/22/2001	WO2001087846A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
11/22/2001	WO2001087844A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
11/22/2001	WO2001087841A1 Novel polymorph v of torasemide
11/22/2001	WO2001087840A1 Propanoic acid derivatives as integrin receptor antagonists
11/22/2001	WO2001087823A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives
11/22/2001	WO2001087304A1 Ophthalmic solution
11/22/2001	WO2001087303A1 Aqueous liquid preparation
11/22/2001	WO2001087298A1 Water-based liquid preparation
11/22/2001	WO2001087267A1 Protein matrix materials, devices and methods of making and using thereof
11/22/2001	WO2001087039A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2
11/22/2001	WO2001046128A3 Tryptase inhibitors
11/22/2001	WO2001034805A3 Human vanilloid receptor gene
11/22/2001	WO2001030781A3 INHIBITORS OF αLβ2 MEDIATED CELL ADHESION
11/22/2001	WO2001028578A3 A PHARMACEUTICAL COMPOSITION CONTAINING pGLU-GLU-PRO-NH2 AND METHOD FOR TREATING DISEASES AND INJURIES TO THE BRAIN, SPINAL CORD AND RETINA USING SAME
11/22/2001	WO2001026674A3 Method for treating otic disorders
11/22/2001	WO2001025239A3 Oxazinoquinolones useful for the treatment of viral infections
11/22/2001	US20010044937 Transgenic intracytoplasmic sperm injection, retroviral gene transfer, intracytoplasmic nuclear injection, and pronuclear injection; useful as models for human disease/diagnosis, assessing safety and efficiency of drug and gene therapy
11/22/2001	US20010044535 Heterocyclic compounds containing a guanidine mimic, for inhibition of cell adhesion, treatment of angiogenesis disorders, inflammation, cancer metastasis, diabetic retinopathy, thrombosis, restenosis, macular degeneration
11/22/2001	US20010044460 Ophthalmic compositions for treating ocular hypertension
11/22/2001	US20010044451 Tyrosine kinase inhibitors
11/22/2001	US20010044144 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor
11/22/2001	US20010043926 Pharmaceutical formulation
11/22/2001	DE10023484A1 New 2-((cycloalkyl- or heterocyclyl-alkyl)-amino)-benzamide derivatives, are VEGF receptor, KDR kinase and FLT kinase inhibitors useful e.g. for treating tumors, psoriasis, arthritis or renal or ophthalmological diseases
11/22/2001	CA2409740A1 Novel aryl, alkenyl, and alkynyl 4-dedimethylaminotetracycline desrivatives
11/22/2001	CA2409699A1 Novel polymorph v of torasemide
11/22/2001	CA2409225A1 Tricyclic pyrazole derivatives
11/22/2001	CA2409035A1 Hydroxamic acid derivatives
11/22/2001	CA2408842A1 Method for treating retinal degeneration with purinergic receptor agonists
11/22/2001	CA2408745A1 Anti-angiogenic polypeptides
11/21/2001	EP1156049A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
11/21/2001	EP1156030A1 Novel quaternary ammonium salt and process for the preparation thereof
11/21/2001	EP1155691A2 Anti-angiogenic compositions and methods of use
11/21/2001	EP1155690A2 Anti-angiogenic compositions and method of use
11/21/2001	EP1155689A2 Anti-angiogenic compositions and methods of use
11/21/2001	EP1155003A1 Novel guanidine derivatives as inhibitors of cell adhesion
11/21/2001	EP1155000A1 2-aminopyridines containing fused ring substituents
11/21/2001	EP1154988A1 Mevinolin derivatives
11/21/2001	EP1154801A1 Integration of transplanted neural progenitor cells into neural tissue of immature and mature dystrophic recipients
11/21/2001	EP1154774A1 Quinazoline derivatives as angiogenesis inhibitors
11/21/2001	EP1154769A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen
11/21/2001	EP1154767A1 Substituted stilbene compounds with vascular damaging activity
11/21/2001	EP1154691A1 Targeted transscleral controlled release drug delivery to the retina and choroid
11/21/2001	EP0952974B1 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
11/21/2001	EP0745081B1 indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
11/21/2001	CN1323302A N-cimidazolylalkyl) substituted cyclic amines as histamine-H3 agonists or antagonists
11/21/2001	CN1323301A Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
11/21/2001	CN1323216A Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
11/21/2001	CN1323209A Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
11/21/2001	CN1323207A Use of ophthalmic composition comprising vitamin A and vitamin E
11/21/2001	CN1074932C Ophthalmic compositions
11/20/2001	US6320062 15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders
11/20/2001	US6320054 Thiazole derivatives
11/20/2001	US6319935 Used in treatment of elevated intraocular pressure, non insulin-dependent diabetes, male impotence and obesity
11/20/2001	US6319934 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium compounds
11/20/2001	US6319922 Propanoic acid derivatives
11/20/2001	US6319920 Muscarinic receptor antagonist used in gastrointestinal, genitourinary tract, respiratory tract, cardiovascular system, central nervous system disorders and in anesthesiology and ophthalmology
11/20/2001	US6319687 Pigment epithelium-derived factor: characterization, genomic organization and sequence of PEDF gene
11/20/2001	US6319464 Added to borate containing compound; antimicrobial activity enhancement
11/15/2001	WO2001085789A2 Extracellular domain of ryk protein for regulating angiogenesis
11/15/2001	WO2001085729A1 Novel vitronectin receptor antagonists
11/15/2001	WO2001085719A1 Ortho-substituted anthranilic acid amides and their use as medicaments
11/15/2001	WO2001085701A1 5-ht7 receptor antagonists
11/15/2001	WO2001085686A2 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes
11/15/2001	WO2001085677A1 Amino acid derivatives and their use as medicines
11/15/2001	WO2001085671A2 Anthranyl amides and their use as medicaments

1 ... 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 ... 531